ADVENZYMES · Basic Materials · Specialty Chemicals
Composite scorecard: 61/100 — Quality 75 · Valuation 60 · Momentum 32
| Share price | ₹319.05 |
| Market cap | ₹3,694 Cr |
| P/E ratio | 21.9 |
| P/B ratio | 2.3 |
| ROE | 13.1% |
| ROCE | 13.6% |
| Dividend yield | 0.77% |
| Book value | ₹145.81 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹746 Cr | ₹174 Cr | 31.0% |
| 2025 | ₹637 Cr | ₹134 Cr | 31.0% |
| 2024 | ₹624 Cr | ₹137 Cr | 33.0% |
| 2023 | ₹541 Cr | ₹104 Cr | 29.0% |
| 2022 | ₹529 Cr | ₹124 Cr | 38.0% |
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-cat